Dose-dependent effects of in vivo antithymocyte globulin during conditioning for allogeneic bone marrow transplantation from unrelated donors in patients with chronic phase CML.

Dose-dependent effects of in vivo antithymocyte globulin during conditioning for allogeneic bone marrow transplantation from unrelated donors in patients with chronic phase CML.

Item
http://www.wikidata.org/entity/Q44511393
Antilymphocyte/thymocyte globulin for graft versus host disease prophylaxis: efficacy and side effects.The efficacy and safety of rabbit anti-thymocyte globulin vs rabbit anti-T-lymphocyte globulin in peripheral blood stem cell transplantation from unrelated donors.Outcomes of peripheral blood stem cell transplantation patients from HLA-mismatched unrelated donor with antithymocyte globulin (ATG)-Thymoglobulin versus ATG-Fresenius: a single-center study.Comparison of different rabbit ATG preparation effects on early lymphocyte subset recovery after allogeneic HSCT and its association with EBV-mediated PTLD.Influence of two different doses of antithymocyte globulin in patients with standard-risk disease following haploidentical transplantation: a randomized trial.Reduced-intensity conditioning with busulfan and fludarabine with or without antithymocyte globulin in HLA-identical sibling transplantation--a retrospective analysis.Reduced-intensity conditioning using TBI (8 Gy), fludarabine, cyclophosphamide and ATG in elderly CML patients provides excellent results especially when performed in the early course of the disease.ATG prevents severe acute graft-versus-host disease in mismatched unrelated donor hematopoietic cell transplantation.Risk factors for acute graft-versus-host disease grades II-IV after reduced intensity conditioning allogeneic stem cell transplantation with unrelated donors: a single centre study.IgG antibodies to ATG early after pediatric hematopoietic SCT increase the risk of acute GVHD.In vivo T-cell depletion with low-dose ATG is effective in reducing cGVHD after peripheral blood stem cell myeloablative sibling transplants in CML: results from a prospective phase II study
P2860

Dose-dependent effects of in vivo antithymocyte globulin during conditioning for allogeneic bone marrow transplantation from unrelated donors in patients with chronic phase CML.

Item
http://www.wikidata.org/entity/Q44511393
description
2003 nî lūn-bûn
@nan
2003年の論文
@ja
2003年学术文章
@wuu
2003年学术文章
@zh-cn
2003年学术文章
@zh-hans
2003年学术文章
@zh-my
2003年学术文章
@zh-sg
2003年學術文章
@yue
2003年學術文章
@zh
2003年學術文章
@zh-hant
name
Dose-dependent effects of in v ...... tients with chronic phase CML.
@en
Dose-dependent effects of in v ...... tients with chronic phase CML.
@nl
type
label
Dose-dependent effects of in v ...... tients with chronic phase CML.
@en
Dose-dependent effects of in v ...... tients with chronic phase CML.
@nl
prefLabel
Dose-dependent effects of in v ...... tients with chronic phase CML.
@en
Dose-dependent effects of in v ...... tients with chronic phase CML.
@nl
P1433
P1476
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P577
P5875
P698
P356
P1433
P1476
Dose-dependent effects of in v ...... tients with chronic phase CML.
@en
P2093
P2860
P2888
P304
P31
P356
P407
P433
P478
P577
P5875
P698